Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013797 |
---|---|
Receipt number | R000015834 |
Scientific Title | A Multicenter, Clinical Phase II study of FOLFOXIRI with Bevacizumab As First-line Therapy in Patients with Metastatic Colorectal Cancer. |
Date of disclosure of the study information | 2014/04/24 |
Last modified on | 2015/08/28 11:51:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/04/23 19:06:47 | ||
2 | Update | 2014/06/27 19:44:19 | Recruitment status |
|
3 | Update | 2014/07/31 12:21:17 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2014/07/31 12:24:16 | Institutions |
|
5 | Update | 2015/08/28 11:42:00 | Recruitment status Last follow-up date |
|
6 | Update | 2015/08/28 11:48:06 | Last follow-up date |
|
7 | Update | 2015/08/28 11:51:02 | Division name Division name Address Address |